The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Inhalers-Global Market Insights and Sales Trends 2024
Synopsis
The global Inhalers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Inhalers in various end use industries. The expanding demands from the Hospital, Clinic, Respiratory Care Centers and Others, are propelling Inhalers market. Metered Dose Inhalers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry Powder Inhalers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Inhalers market, driven by demand from China, the second largest economy with some signs of stabilising, the Inhalers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inhalers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inhalers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inhalers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inhalers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inhalers covered in this report include GlaxoSmithKline, Merck, AstraZeneca, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma and Novartis, etc.
The global Inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
AstraZeneca
Boehringer-Ingelheim
3M
Teva
Sunovion Pharmaceuticals
Aristopharma
Novartis
Vectura Group
MannKind
Respirices
Orion Pharm
Hovione
Global Inhalers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhalers market, Segment by Type:
Metered Dose Inhalers
Dry Powder Inhalers
Nasal Inhalers
Other
Global Inhalers market, by Application
Hospital
Clinic
Respiratory Care Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inhalers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inhalers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Inhalers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Inhalers in various end use industries. The expanding demands from the Hospital, Clinic, Respiratory Care Centers and Others, are propelling Inhalers market. Metered Dose Inhalers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry Powder Inhalers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Inhalers market, driven by demand from China, the second largest economy with some signs of stabilising, the Inhalers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inhalers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inhalers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inhalers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inhalers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inhalers covered in this report include GlaxoSmithKline, Merck, AstraZeneca, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma and Novartis, etc.
The global Inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
AstraZeneca
Boehringer-Ingelheim
3M
Teva
Sunovion Pharmaceuticals
Aristopharma
Novartis
Vectura Group
MannKind
Respirices
Orion Pharm
Hovione
Global Inhalers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhalers market, Segment by Type:
Metered Dose Inhalers
Dry Powder Inhalers
Nasal Inhalers
Other
Global Inhalers market, by Application
Hospital
Clinic
Respiratory Care Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inhalers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inhalers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Inhalers Market Overview
1.1 Inhalers Product Overview
1.2 Inhalers Market Segment by Type
1.2.1 Metered Dose Inhalers
1.2.2 Dry Powder Inhalers
1.2.3 Nasal Inhalers
1.2.4 Other
1.3 Global Inhalers Market Size by Type
1.3.1 Global Inhalers Market Size Overview by Type (2018-2029)
1.3.2 Global Inhalers Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inhalers Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inhalers Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inhalers Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inhalers Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inhalers Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inhalers Sales Breakdown by Type (2018-2023)
2 Global Inhalers Market Competition by Company
2.1 Global Top Players by Inhalers Sales (2018-2023)
2.2 Global Top Players by Inhalers Revenue (2018-2023)
2.3 Global Top Players by Inhalers Price (2018-2023)
2.4 Global Top Manufacturers Inhalers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inhalers Market Competitive Situation and Trends
2.5.1 Inhalers Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inhalers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhalers as of 2022)
2.7 Date of Key Manufacturers Enter into Inhalers Market
2.8 Key Manufacturers Inhalers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inhalers Status and Outlook by Region
3.1 Global Inhalers Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inhalers Historic Market Size by Region
3.2.1 Global Inhalers Sales in Volume by Region (2018-2023)
3.2.2 Global Inhalers Sales in Value by Region (2018-2023)
3.2.3 Global Inhalers Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inhalers Forecasted Market Size by Region
3.3.1 Global Inhalers Sales in Volume by Region (2024-2029)
3.3.2 Global Inhalers Sales in Value by Region (2024-2029)
3.3.3 Global Inhalers Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inhalers by Application
4.1 Inhalers Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Respiratory Care Centers
4.1.4 Others
4.2 Global Inhalers Market Size by Application
4.2.1 Global Inhalers Market Size Overview by Application (2018-2029)
4.2.2 Global Inhalers Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inhalers Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inhalers Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inhalers Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inhalers Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inhalers Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inhalers Sales Breakdown by Application (2018-2023)
5 North America Inhalers by Country
5.1 North America Inhalers Historic Market Size by Country
5.1.1 North America Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inhalers Sales in Volume by Country (2018-2023)
5.1.3 North America Inhalers Sales in Value by Country (2018-2023)
5.2 North America Inhalers Forecasted Market Size by Country
5.2.1 North America Inhalers Sales in Volume by Country (2024-2029)
5.2.2 North America Inhalers Sales in Value by Country (2024-2029)
6 Europe Inhalers by Country
6.1 Europe Inhalers Historic Market Size by Country
6.1.1 Europe Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inhalers Sales in Volume by Country (2018-2023)
6.1.3 Europe Inhalers Sales in Value by Country (2018-2023)
6.2 Europe Inhalers Forecasted Market Size by Country
6.2.1 Europe Inhalers Sales in Volume by Country (2024-2029)
6.2.2 Europe Inhalers Sales in Value by Country (2024-2029)
7 Asia-Pacific Inhalers by Region
7.1 Asia-Pacific Inhalers Historic Market Size by Region
7.1.1 Asia-Pacific Inhalers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inhalers Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inhalers Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inhalers Forecasted Market Size by Region
7.2.1 Asia-Pacific Inhalers Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inhalers Sales in Value by Region (2024-2029)
8 Latin America Inhalers by Country
8.1 Latin America Inhalers Historic Market Size by Country
8.1.1 Latin America Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inhalers Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inhalers Sales in Value by Country (2018-2023)
8.2 Latin America Inhalers Forecasted Market Size by Country
8.2.1 Latin America Inhalers Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inhalers Sales in Value by Country (2024-2029)
9 Middle East and Africa Inhalers by Country
9.1 Middle East and Africa Inhalers Historic Market Size by Country
9.1.1 Middle East and Africa Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inhalers Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inhalers Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inhalers Forecasted Market Size by Country
9.2.1 Middle East and Africa Inhalers Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inhalers Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Inhalers Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Inhalers Products Offered
10.2.5 Merck Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Inhalers Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Boehringer-Ingelheim
10.4.1 Boehringer-Ingelheim Company Information
10.4.2 Boehringer-Ingelheim Introduction and Business Overview
10.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer-Ingelheim Inhalers Products Offered
10.4.5 Boehringer-Ingelheim Recent Development
10.5 3M
10.5.1 3M Company Information
10.5.2 3M Introduction and Business Overview
10.5.3 3M Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.5.4 3M Inhalers Products Offered
10.5.5 3M Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Inhalers Products Offered
10.6.5 Teva Recent Development
10.7 Sunovion Pharmaceuticals
10.7.1 Sunovion Pharmaceuticals Company Information
10.7.2 Sunovion Pharmaceuticals Introduction and Business Overview
10.7.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sunovion Pharmaceuticals Inhalers Products Offered
10.7.5 Sunovion Pharmaceuticals Recent Development
10.8 Aristopharma
10.8.1 Aristopharma Company Information
10.8.2 Aristopharma Introduction and Business Overview
10.8.3 Aristopharma Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aristopharma Inhalers Products Offered
10.8.5 Aristopharma Recent Development
10.9 Novartis
10.9.1 Novartis Company Information
10.9.2 Novartis Introduction and Business Overview
10.9.3 Novartis Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis Inhalers Products Offered
10.9.5 Novartis Recent Development
10.10 Vectura Group
10.10.1 Vectura Group Company Information
10.10.2 Vectura Group Introduction and Business Overview
10.10.3 Vectura Group Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Vectura Group Inhalers Products Offered
10.10.5 Vectura Group Recent Development
10.11 MannKind
10.11.1 MannKind Company Information
10.11.2 MannKind Introduction and Business Overview
10.11.3 MannKind Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.11.4 MannKind Inhalers Products Offered
10.11.5 MannKind Recent Development
10.12 Respirices
10.12.1 Respirices Company Information
10.12.2 Respirices Introduction and Business Overview
10.12.3 Respirices Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Respirices Inhalers Products Offered
10.12.5 Respirices Recent Development
10.13 Orion Pharm
10.13.1 Orion Pharm Company Information
10.13.2 Orion Pharm Introduction and Business Overview
10.13.3 Orion Pharm Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Orion Pharm Inhalers Products Offered
10.13.5 Orion Pharm Recent Development
10.14 Hovione
10.14.1 Hovione Company Information
10.14.2 Hovione Introduction and Business Overview
10.14.3 Hovione Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Hovione Inhalers Products Offered
10.14.5 Hovione Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inhalers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inhalers Industrial Chain Analysis
11.4 Inhalers Market Dynamics
11.4.1 Inhalers Industry Trends
11.4.2 Inhalers Market Drivers
11.4.3 Inhalers Market Challenges
11.4.4 Inhalers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inhalers Distributors
12.3 Inhalers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
